Inhibition of GSK3 promotes replication and survival of pancreatic beta cells

Rainer Mussmann1, Marcus Geese, Friedrich Harder

  • 1DeveloGen AG, Marie-Curie-Strasse 7, Göttingen 37079, Germany.

Insights

Glycogen synthase kinase 3 (GSK3) inhibition promotes beta cell replication and survival. This suggests GSK3 inhibitors could be a novel therapy for diabetes, improving beta cell regeneration.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Regenerative Medicine

Background:

  • Current diabetes therapies often fail to achieve optimal glycemic control.
  • Beta cell regeneration offers a potential alternative treatment strategy.
  • The role of Glycogen Synthase Kinase 3 (GSK3) in beta cell function is under investigation.

Purpose of the Study:

  • To investigate the role of GSK3 in beta cell replication and survival.
  • To evaluate the potential of GSK3 inhibitors as a therapeutic approach for diabetes.

Main Methods:

  • Inactivation of GSK3 in INS-1E rat insulinoma cells using small molecule inhibitors and RNA interference.
  • Assessment of beta cell toxicity under high glucose and palmitate conditions.
  • Treatment of isolated rat islets with diverse GSK3 inhibitors to measure beta cell replication rates.

Main Results:

  • GSK3 inactivation stimulated INS-1E cell replication.
  • Specific GSK3 inhibitors protected INS-1E cells from glucose and palmitate toxicity.
  • Treatment with GSK3 inhibitors increased beta cell replication in isolated rat islets by 2-3 fold.

Conclusions:

  • GSK3 is identified as a key regulator of beta cell replication and survival.
  • GSK3 inhibitors demonstrate potential for beta cell regenerative therapies.
  • Targeting GSK3 may offer a novel strategy for managing diabetes.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...